August 22, 2017 9:15 PM ET

Biotechnology

Company Overview of Biocept, Inc.

Executive Profile

David F. Hale

Executive Chairman, Biocept, Inc.
AgeTotal Calculated CompensationThis person is connected to 18 Board Members in 18 different organizations across 20 different industries.

See Board Relationships
68$100,000

Background

Mr. David F. Hale is Founder and Managing Director of Dermata Therapeutics, LLC. Mr. Hale serves as Advisor at Windamere Venture Partners, LLC. He is a co-founder of CONNECT. He serves as the Chairman and Chief Executive Officer at Hale BioPharma Ventures, LLC. He is Co-Founder, Chairman and Chief Executive Officer at Neurelis, Inc. He co-founded Pernix Sleep, Inc. in August 2003 and served as its interim Chief Executive Officer from January 2008 to August 2008 and Executive ...

Corporate Headquarters

5810 Nancy Ridge Drive
San Diego, California 92121

United States

Phone: 858-320-8200
Fax: 858-320-8225

Board Members Memberships

Trustee
Director
Chairman
Director
Chairman and Chief Executive Officer
Chairman
Co-Founder, Chairman, and Chief Executive Officer
Chairman of The Board
Chairman
Chairman
Founder, Managing Director, and Director
Chairman
Director
2001-Present
Chairman
2006-Present
Chairman
2011-Present
Executive Chairman
2015-Present
Non-Executive Independent Director

Education

BA
Jacksonville State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$100,000
Total Calculated Compensation$100,000
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Francis A. deSouza Chief Executive Officer, President and Director
Illumina, Inc.
$799.6K
David P. King J.D.Chairman, Chief Executive Officer and President
Laboratory Corporation of America Holdings
$1.1M
Jean-Luc Belingard Chairman and Chief Executive Officer
bioMérieux S.A.
$2.2M
Joji Nakayama Chairman & CEO
Daiichi Sankyo Company, Limited
$126.0M
Matthew Rabinowitz Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Natera, Inc.
$452.6K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Biocept, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.